Search Results - "OSHIMI, K"

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type by Suzuki, R., Suzumiya, J., Yamaguchi, M., Nakamura, S., Kameoka, J., Kojima, H., Abe, M., Kinoshita, T., Yoshino, T., Iwatsuki, K., Kagami, Y., Tsuzuki, T., Kurokawa, M., Ito, K., Kawa, K., Oshimi, K.

“…Background: Patients with natural killer (NK) cell neoplasms, aggressive NK cell leukemia (ANKL) and extranodal NK cell lymphoma, nasal type (ENKL), have poor…”
Get full text

Concept and combustion characteristics of ultra-micro combustors with premixed flame by Yuasa, S., Oshimi, K., Nose, H., Tennichi, Y.

“…Under micro-scale combustion influenced by quenching distance, high heat loss, shortened diffusion characteristic time, and flow laminarization, we clarified…”
Get full text

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells by SUZUKI, R, SUZUMIYA, J, KAWA, K, OSHIMI, K, NAKAMURA, S, AOKI, S, NOTOYA, A, OZAKI, S, GONDO, H, HINO, N, MORI, H, SUGIMORI, H

“…Aggressive natural killer-cell leukemia (ANKL) is a rare form of large granular lymphocyte leukemia, which is characterized by a systemic proliferation of NK…”
Get full text

Spontaneous regression of natural killer cell lymphoma by Isobe, Y, Aritaka, N, Sasaki, M, Oshimi, K, Sugimoto, K

“…Spontaneous tumour regression is extremely rare in aggressive lymphoma. A case of natural killer (NK) cell lymphoma with cutaneous manifestation showed an…”
Get more information

Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms by SUZUKI, R, SUZUMIYA, J, SUGIMORI, H, KAWA, K, KODERA, Y, OSHIMI, K, NAKAIMURA, S, KAGAMI, Y, KAMEOKA, J.-I, SAKAI, C, MUKAI, H, TAKENAKA, K, YOSHINO, T, TSUZUKI, T

“…Neoplasms of natural killer (NK)-lineage are rare. Their prognosis is generally poor except for cases of solitary nasal NK-cell lymphoma. The NK-cell Tumor…”
Get full text

Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis by Ahn, H.K., Suh, C., Chuang, S.S., Suzumiya, J., Ko, Y.H., Kim, S.J., Huh, J.R., Yoon, D.H., Oh, S.Y., Kim, J.S., Lee, S.I., Park, K.W., Hsieh, P.P., Nakamura, S., Yoshino, T., Ito, K., Nagatani, T., Oshimi, K., Suzuki, R., Kim, W.S.

“…Clinical features and outcomes of extranodal natural killer/T-cell lymphoma (ENKL) arising from extranasal sites are not fully understood. The purpose of this…”
Get full text

Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group by Fujishima, Naohito, Sawada, Ken-ichi, Hirokawa, Makoto, Oshimi, Kazuo, Sugimoto, Koichi, Matsuda, Akira, Teramura, Masanao, Karasawa, Masamitsu, Arai, Ayako, Yonemura, Yuji, Nakao, Shinji, Urabe, Akio, Omine, Mitsuhiro, Ozawa, Keiya

“…1 Division of Hematology and Oncology, Department of Medicine, Akita University School of Medicine, Akita, Akita 2 Division of Hematology, Juntendo University…”
Get full text

Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate by Isobe, Y., Sugimoto, K., Masuda, A., Hamano, Y., Oshimi, K.

“…Imatinib mesylate (IM) is currently used as the first therapeutic choice against chronic myelogenous leukaemia (CML). Because IM poorly penetrates the…”
Get full text

Epstein-Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis by Isobe, Y, Sugimoto, K, Matsuura, I, Takada, K, Oshimi, K

“…We established two Epstein–Barr virus (EBV)-infected NKL sublines, which acquired stress resistant phenotype against DNA damage and starvation compared with…”
Get full text

Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1 by Sugimoto, K, Sasaki, M, Isobe, Y, Tsutsui, M, Suto, H, Ando, J, Tamayose, K, Ando, M, Oshimi, K

“…Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 n M geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat…”
Get full text

Dlk1 in normal and abnormal hematopoiesis by SAKAJIRI, S, O'KELLY, J, TEISNER, B, KAWAMATA, N, KOEFFLER, H. P, YIN, D, MILLER, C. W, HOFMANN, W. K, OSHIMI, K, SHIH, L.-Y, KIM, K.-H, SUL, H. S, JENSEN, C. H

“…Dlk1 (Pref-1) is a transmembrane and secreted protein, which is a member of the epidermal growth factor-like family, homologous to Notch/Delta/Serrate. We have…”
Get full text

Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature by Oshimi, K

Get more information

Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma by TSUTSUI, M., YASUDA, H., SUTO, H., IMAI, H., ISOBE, Y., SASAKI, M., KOJIMA, Y., OSHIMI, K., SUGIMOTO, K.

“…Summary Nasal natural killer (NK)‐cell lymphoma was resistant to various antitumor agents. Although high expression of p‐glycoprotein has been reported, other…”
Get full text

Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax by SASAKI, M, SUGIMOTO, K, TAMAYOSE, K, ANDO, M, TANAKA, Y, OSHIMI, K

“…Bub1 is a component of the mitotic spindle checkpoint apparatus. Abnormality of this apparatus is known to cause multinuclei formation, a hallmark of…”
Get full text

Upfront Radiotherapy with Concurrent Chemotherapy for Localized Nasal NK/T-Cell Lymphoma: Radiotherapy Quality Assurance (QA) Review in Japan Clinical Oncology Group (JCOG) Trial 0211 by Oguchi, M, Kagami, Y, Ishikura, S, Nihei, K, Ito, Y, Yamaguchi, M, Tobinai, K, Hotta, T, Wasada, I, Oshimi, K

Get full text

Interleukin-11 Enhances Human Megakaryocytopoiesis In Vitro by Teramura, Masanao, Kobayashi, Shoko, Hoshino, Shigeru, Oshimi, Kazuo, Mizoguchi, Hideaki

“…We investigated the effect of recombinant human interieu-kin-11 (rhlL-11) on human megakaryocytopoiesis. Nonadherent and T-cell-depleted human bone marrow (BM)…”
Get full text

Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells by Oshimi, Y, Oshimi, K, Miyazaki, S

“…1. During the process of cell death, rises in cytosolic Ca2+ concentration ([Ca2+]i) together with structural changes were investigated in target cells…”
Get full text

NK-cell lymphomas and NK-like T-cell lymphomas by Oshimi, K

“…Two types of NK(natural killer)-cell lymphomas have been described. One is "nasal and nasal-type NK-cell lymphoma", and the other is "blastic NK-cell…”
Get more information

Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders by Oshimi, K, Yamada, O, Kaneko, T, Nishinarita, S, Iizuka, Y, Urabe, A, Inamori, T, Asano, S, Takahashi, S, Hattori, M

“…The hematological and immunological findings and clinical courses of 33 patients (13 male, 20 female; median age at presentation, 60 years) with granular…”
Get more information

Hemophagocytosis in autoimmune disease by SEKIGAWA, I, SUZUKI, J, NAWATA, M, IKEDA, K, KOIKE, M, IIDA, N, HASHIMOTO, H, OSHIMI, K

“…Reactive hemophagocytic syndrome (HPS) is known to be associated with various autoimmune diseases, as well as infection and/or malignancy. Here we review the…”
Get full text